Analytical and clinical evaluation of the PathoNostics AsperGenius assay for detection of invasive aspergillosis and resistance to azole antifungal drugs during testing of serum samples

Journal of Clinical Microbiology

Volumn 53, Issue 7, 2015, Pages 2115-2121

  White, P Lewis ^a   Posso, Raquel B ^b   Barnes, Rosemary A ^b  

^a PUBLIC HEALTH WALES   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; GENOMIC DNA; TRIAZOLE DERIVATIVE; FUNGAL DNA; GENETIC MARKER; PYRROLE DERIVATIVE;

ADULT; AGED; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DNA EXTRACTION; FEMALE; HUMAN; INVASIVE ASPERGILLOSIS; LIMIT OF DETECTION; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; ADOLESCENT; DRUG EFFECTS; EVALUATION STUDY; GENETIC MARKER; GENETICS; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PROCEDURES; SERUM; VERY ELDERLY; YOUNG ADULT;

ASPERGILLUS; ASPERGILLUS FUMIGATUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPERGILLUS FUMIGATUS; AZOLES; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FEMALE; GENETIC MARKERS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY; SERUM; YOUNG ADULT;

EID: 84932639399     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00667-15     Document Type: Article

References (21)

1. Morrissey CO, Chen SC, Sorrell TC, Milliken S, Bardy PG, Bradstock KF, Szer J, Halliday CL, Gilroy NM, Moore J, Schwarer AP, Guy S, Bajel A, Tramontana AR, Spelman T, Slavin MA. 2013. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis 13:519-528. http://dx.doi.org/10.1016/S1473-3099(13)70076-8.
2. Aguado JM, Vázquez L, Fernández-Ruiz M, Villaescusa T, Ruiz-Camps I, Barba P, Silva JT, Batlle M, Solano C, Gallardo D, Heras I, Polo M, Varela R, Vallejo C, Olave T, López-Jiménez J, Rovira M, Parody R, Cuenca-Estrella M. 2015. Serum galactomannan vs a combination of galactomannan and PCR-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. Clin Infect Dis 60:405-414. http://dx.doi.org/10.1093/cid/ciu833.
3. Barnes RA, Stocking K, Bowden S, Poynton MH, White PL. 2013. Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway. J Infect 67:206-214. http://dx.doi.org/10.1016/j.jinf.2013.04.020.
4. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813-1821. http://dx.doi.org/10.1086/588660.
5. White PL, Perry MD, Moody A, Follett SA, Morgan G, Barnes RA. 2011. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. J Clin Microbiol 49:2169-2174. http://dx.doi.org/10.1128/JCM.00101-11.
6. White PL, Hibbitts SJ, Perry MD, Green J, Stirling E, Woodford L, McNay G, Stevenson R, Barnes RA. 2014. Evaluation of a commercially developed semi-automated PCR-SERS assay for the diagnosis of invasive fungal disease. J Clin Microbiol 52:3536-3543. http://dx.doi.org/10.1128/JCM.01135-14.
7. Torelli R, Sanguinetti M, Moody A, Pagano L, Caira M, De Carolis E, Fuso L, De Pascale G, Bello G, Antonelli M, Fadda G, Posteraro B. 2011. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J Clin Microbiol 49:4273-4278. http://dx.doi.org/10.1128/JCM.05026-11.
8. Chong GL, van de Sande WW, Dingemans GJ, Gaajetaan GR, Vonk AG, Hayette MP, van Tegelen DW, Simons GF, Rijnders BJ. 2015. Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid. J Clin Microbiol 53:868-874. http://dx.doi.org/10.1128/JCM.03216-14.
9. Huttner A, Emonet S, Harbarth S, Renzi G, Kaiser L, Schrenze J. 2014. Polymerase-chain reaction/electrospray ionization-mass spectrometry for the detection of bacteria and fungi in bronchoalveolar lavage fluids: a prospective observational study. Clin Microbiol Infect 20:O1059-O1066. http://dx.doi.org/10.1111/1469-0691.12749.
10. White PL, Mengoli C, Bretagne S, Cuenca-Estrella M, Finnstrom N, Klingspor L, Melchers WJ, McCulloch E, Barnes RA, Donnelly JP, Loeffler J, European Aspergillus PCR Initiative (EAPCRI). 2011. Evaluation of Aspergillus PCR protocols for testing serum specimens. J Clin Microbiol 49:3842-3848. http://dx.doi.org/10.1128/JCM.05316-11.
11. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. 2006. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 42:479-486. http://dx.doi.org/10.1086/499949.
12. van der Linden JWM, Snelders E, Kampinga GA, Rijnders BJA, Mattsson E, Debets-Ossenkopp YJ, Kuijper EJ, Van Tiel FH, Melchers WJG, Verweij PE. 2011. Clinical implications of azole-resistance in Aspergillus fumigatus, the Netherlands, 2007-2009. Emerg Infect Dis 17:1846-1854. http://dx.doi.org/10.3201/eid1710.110226.
13. Spiess B, Postina P., Reinwald M, Cornely OA, Hamprecht A, Hoenigl M, Lass-Florl C, Rath P-M, Steinmann J, Miethke T, Lauten M, Will S, Merker N, Hofmann W-K, Buchheidt B. 2014. Incidence of Cyp51 A key mutations in Aspergillus fumigatus - a study on primary clinical samples of immuno-compromised patients in the period of 1995-2013. PLoS One 9:e103113. http://dx.doi.org/10.1371/journal.pone.0103113.
14. Zhao Y, Stensvold CR, Perlin DS, Arendrup MC. 2013. Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases. J Antimicrob Chemother 68:1497-1504. http://dx.doi.org/10.1093/jac/dkt071.
15. Denning DW, Park S, Lass-Florl C, Fraczek MG, Kirwan M, Gore R, Smith J, Bueid A, Moore CB, Bowyer P, Perlin DS. 2011. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal diseases. Clin Infect Dis 52: 1123-1129. http://dx.doi.org/10.1093/cid/cir179.
16. Arvanitis M, Ziakas PD, Zacharioudakis IM, Zervou FN, Caliendo AM, Mylonakis E. 2014. PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance. J Clin Microbiol 52:3731-3742. http://dx.doi.org/10.1128/JCM.01365-14.
17. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review of and meta-analysis. Lancet Infect Dis 9:89-96. http://dx.doi.org/10.1016/S1473-3099(09)70019-2.
18. Springer J, Morton CO, Perry M, Heinz WJ, Paholcsek M, Alzheimer M, Rogers TR, Barnes RA, Einsele H, Loeffler J, White PL. 2013. Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients. J Clin Microbiol 51:1445-1450. http://dx.doi.org/10.1128/JCM.03322-12.
19. White PL, Barnes RA. 2009. Aspergillus PCR, p 373-388. In Latge JP, Steinbach WJ (ed), Aspergillus fumigatus and aspergillosis, 1st ed. ASM Press, Washington, DC.
20. Torelli R, Sanguinetti M, Brunella E, de Carolis E, de Pascale G, Caira M, Bello G, Antonelli M, Pagano L, Fadda G. 2011. Detection of Aspergillus DNA in bronchoalveolar lavage fluid samples from high risk patients using a commercial real-time PCR assay, abstr P071. Abstr Trends in Med Mycol 5. Valencia, Spain, 2-5 October 2011.
21. Perry MD, White PL, Barnes RA. 2014. Comparison of four automated nucleic acid extraction platforms for the recovery of DNA from Aspergillus fumigatus. J Med Microbiol 63:1160-1166. http://dx.doi.org/10.1099/jmm.0.076315-0.